This review positions aucubin as a biologically informative iridoid glycoside with substantial scaffold-level relevance for future natural-product-inspired therapeutic development, rather than as a near-term clinical drug candidate.
M. Arafat, Mostafa K. Mohammad, Kareem A. Attallah et al.· European Journal of Pharmaco...· 0 citations
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral disturbance, largely associated with amyloid-β accumulation, tau protein pathology, synaptic dysfunction, oxidative stress and neuroinflammation. Previous research emphasizes the critical...
A. Shaheen, Mou-Sa A. Mai, Merhan O. Hindam et al.· Frontiers in Pharmacology· 2 citations
In silico ADME profiling demonstrated promising pharmacokinetic behavior, characterized by robust gastrointestinal absorption and excellent predicted blood–brain barrier penetration, supporting the potential of these derivatives as promising multifunctional candidates for the development of anti‐Alzheimer agents.
Aisha A. Alsfouk, Riham A. El-Shiekh, Benson M Kariuki et al.· Drug development research (P...· 0 citations
The findings obtained here demonstrate the potential of A. officinalis L. spears for pharmaceutical, agricultural, and food industry applications and demonstrates significant in vitro inhibition of the biofilm formation and enhanced biofilm detachment against MRSA.
Passent M. Abdel-Baki, Mariam Hassan, Noha A. Ahmed et al.· RSC Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.